An observational study in Hepatocellular Carcinoma (HCC), sponsored by Hospital Universitario La Paz. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Hospital Universitario La Paz · Observational
Longitudinal, prospective, observational, non-interventional study, to evaluate the performance of tumour biomarkers Alpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3), and protein induced by vitamin K absence or antagonist-II (PIVKA-II) and their combinations (GAAD and GALAD algorithms) in the screening of HCC.
3,251 studies on the registry are indexed under Carcinoma, Hepatocellular; 974 are open to participants now.
This study's enrollment of 417 is above the median of 200 across 769 observational studies indexed under Carcinoma, Hepatocellular.
Browse Carcinoma, Hepatocellular studies →Hospital Universitario La Paz is the lead sponsor of 55 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients will be selected from among all those who come in for a liver ultrasound according to EASL recommendations of HCC surveillance
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
US imaging of the liver will be performed with grayscale and colour Doppler US in transverse and longitudinal views, taking care to depict the entire liver.
Alpha-fetoprotein (AFP)
tumour biomarkers measured by blood test
Time frame: Every 6 motnhs
Plan to share: Yes — The results of the clinical study will be documented in a clinical study report and if possible, will be published (e.g. in a journal or presented in a scientific meeting).
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitario La Paz